BIOMARKER VALIDATION AND APPLICATION IN EARLY DRUG DEVELOPMENT: IDEA TO PROOF OF CONCEPT

• Published in: Translational Medicine and Drug Discovery pp. 195 - 221
• Main Author: Global, Pfizer
• Format: Book Chapter
• Language: English
• Published: Cambridge University Press 31.01.2011
• Subjects: Pharmaceuticals; Pharmaceuticals, Cosmetics & Toiletries

Editors' Note: In 2004, Pfizer leadership sponsored the creation of a confidential “Biomarker Best Practices” document by a cross-discipline and cross-development team of experts that we would today call a “translational research team” or “advisory group.” This work was completed, and Pfizer de...